Lanie K Francis

Combination of the mTOR Inhibitor Rapamycin with the HSP90 Inhibitor 17-AAG Has Synergistic Activity in EBV Positive Post Transplant Lymphoproliferative Disorders (PTLD).

I. Ghobrial, Alissa J. Huston, Y. Alsayed, 2005 .

The accuracy of predicting survival in individual patients with cancer.

D. Kondziolka, J. Flickinger, L. Lunsford, 2014, Journal of neurosurgery.

Fortifying the Treatment of Prostate Cancer with Physical Activity

R. Klement, C. Champ, Ryan P. Smith, 2016, Prostate cancer.

Prostate Cancer Advances in Radiotherapy for Prostate Cancer Treatment

R. Klement, C. Champ, Ryan P. Smith, 2016 .

Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma

T. Hideshima, G. Roodman, H. Ngo, 2006, Clinical Cancer Research.

Development of an Oncologist-Driven Integrative Intervention for Symptom Management in an Academic Cancer Center.

M. Weiss, Lanie K Francis, C. Faria, 2019, Journal of oncology practice.

A Post-Modern view of women in Hematology : A Focus on work / Life Balance

Lanie K Francis, 2012 .